What is the Revised Geneva Score?
The Revised Geneva Score is a clinical prediction rule used to estimate the pre-test probability of pulmonary embolism (PE). It was developed to provide an objective, standardized approach to PE risk assessment based entirely on clinical variables — unlike the Wells score, it does not include a subjective "PE is the most likely diagnosis" criterion.
The score was first published by Le Gal et al. in 2006 as an update to the original Geneva score from 2001. It uses eight clinical variables (nine items, as heart rate has two tiers) to stratify patients into low, intermediate, or high probability categories for PE.
Scoring Criteria
| Criterion | Original Points | Simplified Points |
|---|---|---|
| Age > 65 years | +1 | +1 |
| Previous PE or DVT | +3 | +1 |
| Surgery or fracture ≤ 1 month | +2 | +1 |
| Active malignancy | +2 | +1 |
| Unilateral lower limb pain | +3 | +1 |
| Hemoptysis | +2 | +1 |
| Heart rate 75–94 bpm | +3 | +1 |
| Heart rate ≥ 95 bpm | +5 | +1 |
| Pain on deep vein palpation + unilateral edema | +4 | +1 |
Interpretation & Risk Categories
| Score Range | Category | PE Prevalence | Action |
|---|---|---|---|
| Original: 0–3 Simplified: 0–1 | Low Probability | ~8% | D-dimer testing; if negative, PE excluded |
| Original: 4–10 Simplified: 2–4 | Intermediate Probability | ~28% | D-dimer testing; if positive, CT pulmonary angiography (CTPA) |
| Original: ≥ 11 Simplified: ≥ 5 | High Probability | ~74% | CTPA directly (D-dimer not useful to exclude) |
Diagnostic Algorithm Diagram
Simplified vs. Original Version
The simplified version, published by Klok et al. in 2008, assigns 1 point per criterion instead of weighted points. This makes bedside calculation easier without significantly reducing diagnostic accuracy. Studies show the simplified version has similar sensitivity and specificity to the original.
| Feature | Original Version | Simplified Version |
|---|---|---|
| Point range | 0–25 | 0–9 |
| Low probability | 0–3 | 0–1 |
| Intermediate probability | 4–10 | 2–4 |
| High probability | ≥ 11 | ≥ 5 |
| Ease of use | Requires remembering different point values | Simple count of criteria present |
| Validation | Multiple large studies | Validated against original with non-inferior performance |
Geneva Score vs. Wells Score
Both the Revised Geneva Score and the Wells Score for PE are widely used clinical prediction rules. Key differences include:
- Objectivity: The Geneva Score uses only objective clinical variables, while the Wells Score includes a subjective criterion ("PE is #1 diagnosis or equally likely")
- Variables: Geneva emphasizes age, heart rate, and leg signs; Wells includes immobilization and clinical gestalt
- Performance: Both scores have comparable sensitivity and specificity for PE diagnosis in validation studies
- Setting: The Geneva Score may be preferred in settings where clinical experience varies (e.g., emergency departments with junior staff) due to its fully objective nature
D-dimer in the PE Workup
D-dimer is a fibrin degradation product that is elevated in the presence of blood clots. Its role in the PE workup depends on the pre-test probability:
- Low/intermediate probability: A negative D-dimer (using a high-sensitivity assay, typically < 500 ng/mL) can safely exclude PE without imaging
- High probability: D-dimer should NOT be used to exclude PE because the high pre-test probability means even a negative D-dimer has an unacceptable false-negative rate
- Age-adjusted cutoff: For patients > 50 years, an age-adjusted D-dimer threshold (age × 10 ng/mL) increases specificity without significantly reducing sensitivity
Frequently Asked Questions
When should I use the Geneva Score vs. the Wells Score?
Both are acceptable for PE risk assessment. The Geneva Score may be preferred when you want a fully objective tool without subjective clinical judgment components. The Wells Score is more widely used in North America. Choose whichever is standard at your institution. Both are endorsed by major guidelines (ESC, ATS, ACEP).
Can the Geneva Score be used in pregnant patients?
The Geneva Score was not specifically validated in pregnant patients. Pregnancy itself is a risk factor for PE that is not captured by the score. Clinical judgment and modified diagnostic algorithms (often starting with lower extremity ultrasound) are recommended for pregnant patients with suspected PE.
What if the heart rate criteria overlap with other conditions?
The heart rate criteria in the Geneva Score reflect the physiological response to PE (tachycardia). However, many conditions cause tachycardia (pain, anxiety, fever, dehydration). The score accepts this non-specificity because it is designed as a screening tool — higher sensitivity at the cost of some specificity is appropriate for a potentially lethal condition like PE.
Can I use this score in outpatient settings?
Yes. The Geneva Score was validated in both emergency department and outpatient settings. In low-probability patients with a negative D-dimer, the 3-month risk of PE is less than 1%, which is considered safe for outpatient management without anticoagulation or further imaging.